Value-Based Healthcare: Industry Endgame
Analysis
Moving the focus of healthcare from sickness treatment to sustained health demands disruption and structural change.
How to Address Mental Health Amid COVID-19?
Analysis
A global pandemic has demonstrated that we can all be a support for other. Here is how to take care of mental health for you and those around you.
Technology Paves The Way To Integral Health Provision
Analysis
MBN interviewees share their vision on how to take advantage of technology to improve healthcare services and ensure accessibility.
Omar Lugo Country Lead, nPVU and Market Access, Operations Head, UCB Mexico and Latin America
View from the Top
Omar Lugo
Country Lead, nPVU and Market Access, Operations Head
UCB Mexico and Latin America
Omar Lugo says the key behind UCB’s innovation and growth has been listening to the patient.
Pharma Opinions on the “Payment By Results” Model
Analysis
Pharmaceutical industry leaders share their views on the “payment by results” method to increase healthcare access.
Daniel Amezcua
View from the Top
Daniel Amezcua
Director General
UCB
UCB is a biopharmaceutical company that has specialized in serious diseases since 1928, mainly in two therapeutic areas: neurology and immunology.
Subscribe to UCB